Topics

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Articles

In this latest Harvard Business School Healthcare Alumni Association Q&A, Ayelet Israeli, PhD, explains the potential—as well as limitations—of these offerings and pragmatic guardrails for deployment in organizations. 

Leveraging Data for Informed Decision Making

Expansion expected to create additional production capacity, company says.

Novo Nordisk to Invest Over $2B in Danish Manufacturing Facilities

In this latest Harvard Business School Healthcare Alumni Association Q&A, Susan Wilner Golden, DSc, lecturer at the Stanford Graduate School of Business, reveals an untapped $22 trillion global opportunity for all companies and others supporting healthy aging and longer life spans.
 


Embracing the 60-Plus Economy

Decision is anticipated to boost operational efficiencies for the CDMO.

KBI Biopharma, Selexis SA Merge as One Organization

The Medicare Part D cap in 2025 won’t solve patients’ need for financial assistance.

Addressing Rx Affordability

How current frameworks influence coverage decisions and pricing negotiations.

The Evolving Value Assessment Landscape in the US

Document reveals that 20 of 28 of participating Big Pharma manufacturers saw their DIO increase by an average of 5%, suggesting that large amounts of inventory do not necessarily offer protection from running low on medication.

nVentic Report: Manufacturer Inventories Fail to Prevent Medicine Shortages

Financial commitment will allow the firm to further build upon its resources and capabilities in assisting pharma clients. 

Beghou Consulting Secures Investment from Varsity Healthcare Partners

Acquisition is expected to drive organization’s ‘next phase of growth.’

Private Investment Consortium Purchases Syneos Health for $7.1 Billion

A ‘next generation’ CRM platform will gradually leave the Salesforce.com platform behind.

Business and Finance